Raises FY24 GAAP EPS view to approximately $3.92-$3.96 from approximately $3.88-$3.98. Raises FY24 transaction margin dollar view to mid single digit growth from low to mid single digit growth. Now ...
CVS Health Corporation CVS posted second-quarter 2025 adjusted earnings per share (EPS) of $1.81, down 1.1% year over year. The metric topped the Zacks Consensus Estimate by 23.1%. The adjusted EPS ...
PVH Corp. PVH reported second-quarter fiscal 2024 results, wherein both earnings and revenues topped the Zacks Consensus Estimate. The bottom line significantly improved while the top line fell year ...
Gilead Sciences, Inc. GILD reported first-quarter 2026 adjusted earnings per share (EPS) of $2.03, which beat the Zacks Consensus Estimate of $1.89. In the year-ago quarter, the company reported an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results